MBNL proteins in health, disease, and therapeutic applications. [PDF]
Musiała-Kierklo N +4 more
europepmc +1 more source
Cardiac Involvement in Myotonic Dystrophy Type 1: Mechanisms, Clinical Perspectives, and Emerging Therapeutic Strategies. [PDF]
Ginjupalli VKM +4 more
europepmc +1 more source
Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective. [PDF]
Kuntawala DH +4 more
europepmc +1 more source
Identification of enzymatically modified isoquercitrin as a therapeutic lead for myotonic dystrophy type 1. [PDF]
Mishra SK +16 more
europepmc +1 more source
A systems perspective on rare diseases: integrating human phenotype ontology with the Anukta framework of Ayurveda. [PDF]
Jangir D +4 more
europepmc +1 more source
Severe Adult-Onset Non-Dystrophic Myotonia With Apnea and Laryngospasm Due to Digenic Inheritance of SCN4A and CLCN1 Variants: A Case Report. [PDF]
Tugizova M +6 more
europepmc +1 more source
Myotonia Congenita in Australian Merino Sheep with a Missense Variant in CLCN1. [PDF]
Manning LK +10 more
europepmc +1 more source
Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness. [PDF]
Jennings K +7 more
europepmc +1 more source
Quantitative susceptibility mapping in myotonic dystrophy: clinical relevance of subcortical iron accumulation. [PDF]
Fiscone C +14 more
europepmc +1 more source

